Skip to main content
Figure 3 | Cardiovascular Ultrasound

Figure 3

From: The role of renin angiotensin system antagonists in the prevention of doxorubicin and trastuzumab induced cardiotoxicity

Figure 3

Survival probability at the end of 13 weeks for C57Bl/6 mice receiving prophylactic treatment with RAS inhibitors Aliskiren, Perindopril or Valsartan and then treated with anti-cancer drugs TRZ, DOX or the combination of DOX+TRZ. *p < 0.05 significant as compared to TRZ. #p < 0.05 comparing placebo to either Aliskiren, Perindopril, or Valsartan.

Back to article page